A population-based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series.

Autor: Smith CJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Thomas JW; Division of Hematology and Oncology, University of Virginia, Charlottesville, Virginia, USA., Ruan G; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Hyun MC; Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA., Bansal R; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., McLaughlin N; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Pardanani A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Gangat N; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Go RS; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Szuber N; Department of Hematology, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Canada., Goyal G; Division of Hematology-Oncology, University of Alabama, Birmingham, Alabama, USA., Shah MV; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA., Tefferi A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2021 Dec 01; Vol. 96 (12), pp. E464-E468. Date of Electronic Publication: 2021 Oct 26.
DOI: 10.1002/ajh.26377
Databáze: MEDLINE